Kylee Pulsipher
Psychiatric/Mental Health · Sandy, UTNPI 1528609880
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$640
- Neurocrine Biosciences, Inc.$500
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$436
- Teva Pharmaceuticals USA, Inc.$435
- Johnson & Johnson$290
- Vanda Pharmaceuticals Inc.$284
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,764100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $640 |
| Neurocrine Biosciences, Inc. | 20 | $500 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $436 |
| Teva Pharmaceuticals USA, Inc. | 40 | $435 |
| Johnson & Johnson | 16 | $290 |
| Vanda Pharmaceuticals Inc. | 11 | $284 |
| Alkermes, Inc. | 14 | $281 |
| Otsuka America Pharmaceutical, Inc. | 13 | $281 |
| Tris Pharma Inc | 11 | $219 |
| Corium, LLC | 17 | $209 |
| Lundbeck LLC | 10 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $143 |
| Axsome Therapeutics, Inc. | 7 | $139 |
| Biogen | 8 | $139 |
| Braeburn Inc. | 5 | $84 |
| Indivior Inc. | 5 | $83 |
| Ironshore Pharmaceuticals Inc. | 4 | $82 |
| Idorsia Pharmaceuticals US Inc | 5 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $65 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Noven Therapeutics, LLC | 2 | $32 |
| Boston Scientific | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Tempus AI, Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
How this compares
$4,764 in reported general payments places this provider in the 90th percentile of 393 psychiatric/mental health providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 15 | $33,573 |
| VraylarCariprazine Hcl | 13 | $18,814 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $1,456 |
| Clonazepam | 47 | $801 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 30 | $766 |
| Aripiprazole | 20 | $420 |
| Olanzapine | 23 | $388 |
| Bupropion Hcl SrBupropion Hcl | 21 | $350 |
| Lamotrigine | 33 | $320 |
| Mirtazapine | 24 | $255 |
| Gabapentin | 23 | $245 |
| Risperidone | 13 | $200 |
| Methocarbamol | 12 | $197 |
| Trazodone Hcl | 30 | $195 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $290 | $33,57315 claims |
| AbbVieVraylar | $640 | $18,81413 claims |
| Lilly USA, LLCOlanzapine | $20 | $38823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 393 psychiatric/mental health providers in Utah.
Other psychiatric/mental health in Sandy
- Sumer AndersonSandy$8K
- Jennifer OlsenSandy$6K
- Kim McKinnonSandy$6K
- Landon MoyersSandy$6K
- Bret HafenLayton$381K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
- Debra HainRiverton$29K
- Kristin BarberSalt Lake City$28K
- Briana TerrySalt Lake City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.